Subscribe

Shitanshu Uppal

PORTEC-4a: Molecular Profile-Based Adjuvant Treatment for High-Intermediate Risk Endometrial Cancer

AtTEnd: Atezolizumab plus Chemotherapy for Advanced or Recurrent Endometrial Cancer

SOLO2/ENGOT-Ov21: Maintenance Olaparib in Platinum-Sensitive Relapsed Ovarian Cancer (Final OS Analysis)

AURELIA: Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer

RTOG 90-01 (Morris): Pelvic Radiation + Concurrent Cisplatin/5-FU vs Extended-Field Radiation Alone for Locally Advanced Cervical Cancer

GOG 242: Second Curettage for Low-Risk Nonmetastatic GTN

GOG 174: Weekly Methotrexate vs. Pulsed Dactinomycin for Low-Risk GTN

Publications Update # 142

ASCO update on RUBY and GY018, Mirvetuximab and Cataract risk, and two ASCO posters and an article promoting professional friendships

Trastuzumab in HER2-Positive Uterine Serous Carcinoma (Fader)

ICON4/AGO-OVAR-2.2: Paclitaxel–Platinum vs Platinum in Platinum-Sensitive Relapsed Ovarian Cancer